Human Embryo Gene Editing Gets a Road Map—Not a Green Light
By Megan Molteni,
Wired
| 09. 03. 2020
FOR DECADES, SCIENTISTS have been tinkering with genes—cutting and pasting bits of DNA into organisms like plants, bacteria, and mice. So, of course, they thought about the possibility that one day someone might use such tools to alter human genes, even human germlines—making changes to people’s DNA that they’d pass on to future generations.
In 2012 these dreams (or nightmares, depending on where you stand) started to get real. With the emergence of Crispr, genetic manipulations were suddenly much easier to make and the tools to make them quick and cheap to obtain. The National Academy of Sciences arranged summits and reports in an attempt to set some boundaries. In 2017 the academy concluded that using Crispr for human genetic enhancement was a hard no. But they stopped short of a full moratorium. What about gene editing to address serious, incurable diseases? Well, that could maybe one day be fine, provided it was proven safe and effective.
But that 2017 report didn’t spell out exactly how one might prove those things. And a year later, into that...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...